Essential medicines and health products

Ghana bolsters medicines regulatory system, guarantees product quality

Ghana has strengthened its medicines regulatory system to ensure safety, quality and effectiveness of medical products manufactured, imported or distributed within the country, the World Health Organization (WHO) announced today.
Ghana becomes the second country in the WHO African Region to attain regulatory system “Maturity Level 3” – the second-highest in the four-tiered WHO classification of national medicines regulatory systems. Evaluations of Ghana Food and Drugs Authority – the national regulatory body for medicines – were carried out in 2014, 2015 and 2019 through the WHO Global Benchmarking Tool.

CND accepts all WHO recommendations on the control of several psychoactive substances from the 42nd ECDD meeting

During its 63rd session, the Commission on Narcotic Drugs (CND) accepted all recommendations from the 42nd meeting of the WHO Expert Committee on Drug Dependence (ECDD). This effectively brings twelve psychoactive substances, including eleven New Psychoactive Substances (NPS) and one medicine, under international control. Given the potential for dependence or abuse and known adverse effects, these compounds pose a risk to public health and society and are largely without any therapeutic benefit.

WHO launch eEML

The World Health Organization has launched a new easy-to-access, digital version of its Model list of Essential Medicines (EML). The move will revolutionize the way this core WHO reference tool is used.

在线观看|影视免费观看vip More than 150 countries currently use the WHO list to work out which medicines best meet their national health contexts and priorities, so they can compile their own national essential medicines lists.

Public hearing on WHO guideline on ensuring balanced national policies for access and safe use of controlled medicines

在线观看|影视免费观看vipA public hearing regarding the scope of the WHO guideline on ensuring balanced national policies for access and safe use of controlled medicines, will take place on Wednesday February 19, at 14:00 CET. You can register to submit a written statement, or to present an oral statement at the hearing until Monday February 17, 12.00 CET.

WHO publishes Emergency Use Listing procedure and roadmap to make new medical products more readily available during health emergencies


WHO today published the Emergency Use Listing (EUL) procedure to streamline the process by which new or unlicensed products can be used during public health emergencies. The EUL replaces the Emergency Use Assessment and Listing (EUAL) procedure, which was used during the West Africa Ebola outbreak of 2014-2016.
The EUL is a risk-based procedure for assessing and listing unlicensed vaccines, therapeutics and in vitro diagnostics with the ultimate aim of expediting the availability of these products to people affected by a public health emergency.

WHO calls for sustainable funding to boost vaccine safety systems and communication

在线观看|影视免费观看vipAt this week’s Global Vaccine Safety Summit, WHO presented its new strategy for 2021-2030 to boost vaccine safety systems in all countries. The strategy provides a strong focus on communicating the safety of vaccines based on robust evidence and leveraging new communication tools and approaches to allow for informed decision-making on vaccination.

WHO launches first-ever insulin prequalification programme to expand access to life-saving treatment for diabetes

The decision, announced ahead of World Diabetes Day (14 November), is part of a series of steps WHO will take to address the growing diabetes burden in all regions. About 65 million people with type 2 diabetes need insulin, but only half of them are able to access it, largely due to high prices. All people with type 1 diabetes need insulin to survive.

The WHO essential medicines and health products programme works to increase access to essential, high-quality, safe, effective and affordable medical products.